Arena Pharmaceuticals Announces First Subject Dosed in Phase 2 Trial Evaluating Etrasimod in Alopecia Areata
On September 1st, 2020, Arena Pharmaceuticals announced that the first subject has been dosed in Phase 2 of their trial
CSPA Survey: Access to Dermatology Care
The Canadian Skin Patient Alliance (CSPA) is conducting a survey on the impact of COVID-19 on access to dermatology care.
A Special Message From Rosie!
This Saturday, August 29th at 1 pm ET, Coming Up Rosies will be joining CANAAF on Zoom for a scarf
Coming Up Rosies Scarf Making Party
This unique Zoom event is open to all adults and children with alopecia across Canada. Date: August 29 @ 1:00
Research Articles on Healthcare Inequalities in Canada
CANAAF stand with the Black community in the fight against anti-Black racism! #BlackLivesMatter! Minority populations, especially Black and Indigenous communities,
Remission of Alopecia Universalis in a Patient with Atopic Dermatitis Treated with Dupilumab
Atopic Dermatitis (AD), a type of eczema, is an inflammatory skin disorder that causes redness, itching and dryness. It has